SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (20603)4/16/1999 3:52:00 AM
From: Andreas Samson  Read Replies (2) of 23519
 
Any chance they booked a deal under the wire at the close of the quarter? By the estimates you posted...

>>1)Domestic sales about $3.5M
2)International sales about 1/2 of Q4 1998--my guess is about $3.5M
3)Milestone payments of $4M accounts for 12.5 cents profits.<<

To break even before milestone would require a $3.36M cut in OPEX from $10.36M Q498, which looked like this:

Cost of goods sold 6,133
Research and development 2,266
Selling, general and administrative 1,961
Total 10,360

Where would the $3.36M have come from? OPEX is already down 67% from a year ago. Domestic sales may better than you think, which would be, of course, a good sign.

Blood, baby, blood
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News